Mechanisms of Hepatic Fibrogenesis

Friedman, 2007, Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference, Hepatology, 45, 242, 10.1002/hep.21459

Hadziyannis, 2006, Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years, Gastroenterology, 131, 1743, 10.1053/j.gastro.2006.09.020

Bruno, 2007, Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study, Hepatology, 45, 579, 10.1002/hep.21492

Veldt, 2007, Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis, Ann Intern Med, 147, 677, 10.7326/0003-4819-147-10-200711200-00003

Omary, 2007, The pancreatic stellate cell: a star on the rise in pancreatic diseases, J Clin Invest, 117, 50, 10.1172/JCI30082

Friedman, 1993, Seminars in medicine of the Beth Israel Hospital, Boston, N Engl J Med, 328, 1828

Friedman, 2000, Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury, J Biol Chem, 275, 2247, 10.1074/jbc.275.4.2247

Schluger, 1996, Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation, Hepatology, 23, 971, 10.1002/hep.510230505

Bonnard, 2007, Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count, J Viral Hepat, 14, 806, 10.1111/j.1365-2893.2007.00874.x

Lee, 2007, Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte?, Hepatology, 45, 817, 10.1002/hep.21564

Dev, 2006, Relationship of smoking and fibrosis in patients with chronic hepatitis C, Clin Gastroenterol Hepatol, 4, 797, 10.1016/j.cgh.2006.03.019

Iredale, 2007, Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ, J Clin Invest, 117, 539, 10.1172/JCI30542

Zeisberg, 2007, Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition, J Biol Chem, 282, 23337, 10.1074/jbc.M700194200

De Minicis, 2007, Gene expression profiles during hepatic stellate cell activation in culture and in vivo, Gastroenterology, 132, 1937, 10.1053/j.gastro.2007.02.033

Parola, 2001, Oxidative stress-related molecules and liver fibrosis, J Hepatol, 35, 297, 10.1016/S0168-8278(01)00142-8

Jaeschke, 2006, Mechanisms of liver injury, Am J Physiol, 290, G1083

Castillo, 1992, Role of cytochrome P-450 2E1 in ethanol-, carbon tetrachloride- and iron-dependent microsomal lipid peroxidation, Hepatology, 16, 992, 10.1002/hep.1840160423

Chitturi, 2001, Etiopathogenesis of nonalcoholic steatohepatitis, Semin Liver Dis, 21, 27, 10.1055/s-2001-12927

De Minicis, 2007, NOX in liver fibrosis, Arch Biochem Biophys, 462, 266, 10.1016/j.abb.2007.04.016

Bataller, 2003, NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis, J Clin Invest, 112, 1383, 10.1172/JCI18212

Nussler, 1992, Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin, J Exp Med, 176, 261, 10.1084/jem.176.1.261

Venkatraman, 2004, The role of iNOS in alcohol-dependent hepatotoxicity and mitochondrial dysfunction in mice, Hepatology, 40, 565, 10.1002/hep.20326

Jaeschke, 2002, Inflammation in response to hepatocellular apoptosis, Hepatology, 35, 964, 10.1053/jhep.2002.0350964

Canbay, 2004, Apoptosis: the nexus of liver injury and fibrosis, Hepatology, 39, 273, 10.1002/hep.20051

Zhan, 2006, Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo, Hepatology, 43, 435, 10.1002/hep.21093

Watanabe, 2007, Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via Toll-like receptor 9, Hepatology, 46, 1509, 10.1002/hep.21867

Takehara, 2004, Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses, Gastroenterology, 127, 1189, 10.1053/j.gastro.2004.07.019

Canbay, 2002, Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis, Gastroenterology, 123, 1323, 10.1053/gast.2002.35953

Pockros, 2007, Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C, Hepatology, 46, 324, 10.1002/hep.21664

Taimr, 2003, Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis, Hepatology, 37, 87, 10.1053/jhep.2003.50002

Wright, 2001, Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats, Gastroenterology, 121, 685, 10.1053/gast.2001.27188

Anan, 2006, Proteasome inhibition induces hepatic stellate cell apoptosis, Hepatology, 43, 335, 10.1002/hep.21036

Jaeschke, 2004, Apoptosis and necrosis in liver disease, Liver Int, 24, 85, 10.1111/j.1478-3231.2004.0906.x

Wagner, 2006, All is not Toll: new pathways in DNA recognition, J Exp Med, 203, 265, 10.1084/jem.20052191

Paik, 2003, Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells, Hepatology, 37, 1043, 10.1053/jhep.2003.50182

Hua, 2007, Expression of Toll-like receptor 4 in rat liver during the course of carbon tetrachloride-induced liver injury, J Gastroenterol Hepatol, 22, 862, 10.1111/j.1440-1746.2007.04896.x

Seki, 2007, TLR4 enhances TGF-beta signaling and hepatic fibrosis, Nat Med, 13, 1324, 10.1038/nm1663

Huang, 2007, A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C, Hepatology, 46, 297, 10.1002/hep.21695

Mehal, 2007, The role of inflammation and immunity in the pathogenesis of liver fibrosis, Vol 2, 99

Safadi, 2004, Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes, Gastroenterology, 127, 870, 10.1053/j.gastro.2004.04.062

Benhamou, 1999, Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients, Hepatology, 30, 1054, 10.1002/hep.510300409

Radaeva, 2006, Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners, Gastroenterology, 130, 435, 10.1053/j.gastro.2005.10.055

Melhem, 2006, Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC, J Hepatol, 45, 60, 10.1016/j.jhep.2005.12.025

Radaeva, 2007, Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1, Am J Physiol, 293, G809

Jeong, 2008, Abrogation of the anti-fibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis, Gastroenterology, 134, 248, 10.1053/j.gastro.2007.09.034

Winau, 2007, Ito cells are liver-resident antigen-presenting cells for activating T cell responses, Immunity, 26, 117, 10.1016/j.immuni.2006.11.011

Chen, 2006, In vivo immune modulatory activity of hepatic stellate cells in mice, Hepatology, 44, 1171, 10.1002/hep.21379

Novobrantseva, 2005, Attenuated liver fibrosis in the absence of B cells, J Clin Invest, 115, 3072, 10.1172/JCI24798

Wells, 2004, Autocrine release of TGF-beta by portal fibroblasts regulates cell growth, FEBS Lett, 559, 107, 10.1016/S0014-5793(04)00037-7

Jhandier, 2005, Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2, J Biol Chem, 280, 22986, 10.1074/jbc.M412371200

Beaussier, 2007, Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries, Lab Invest, 87, 292, 10.1038/labinvest.3700513

Kisseleva, 2006, Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis, J Hepatol, 45, 429, 10.1016/j.jhep.2006.04.014

Forbes, 2004, A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis, Gastroenterology, 126, 955, 10.1053/j.gastro.2004.02.025

Kruglov, 2006, Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts, Am J Physiol, 290, G765

Dranoff, 2004, Expression of P2Y nucleotide receptors and ectonucleotidases in quiescent and activated rat hepatic stellate cells, Am J Physiol, 287, G417

Sakaida, 2004, Transplantation of bone marrow cells reduces CCl(4)-induced liver fibrosis in mice, Hepatology, 40, 1304, 10.1002/hep.20452

Terai, 2006, Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy, Stem Cells, 24, 2292, 10.1634/stemcells.2005-0542

Nakamura, 2007, Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model, Gastroenterology, 133, 91, 10.1053/j.gastro.2007.03.110

Wang, 2007, Role of alphavbeta6 integrin in acute biliary fibrosis, Hepatology, 46, 1404, 10.1002/hep.21849

Jarnagin, 1994, Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis, J Cell Biol, 127, 2037, 10.1083/jcb.127.6.2037

George, 2000, Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform, Am J Pathol, 156, 115, 10.1016/S0002-9440(10)64711-6

Yang, 2003, Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors, Gastroenterology, 124, 147, 10.1053/gast.2003.50012

Zhou, 2004, Engagement of alphavbeta3 integrin regulates proliferation and apoptosis of hepatic stellate cells, J Biol Chem, 279, 23996, 10.1074/jbc.M311668200

Melton, 2007, Focal adhesion disassembly is an essential early event in hepatic stellate cell chemotaxis, Am J Physiol, 293, G1272

Shafiei, 2006, The role of integrin-linked kinase in liver wound healing, J Biol Chem, 281, 24863, 10.1074/jbc.M513544200

Zhang, 2006, Involvement of integrin-linked kinase in carbon tetrachloride-induced hepatic fibrosis in rats, Hepatology, 44, 612, 10.1002/hep.21315

Yee, 1998, Rho directs activation-associated changes in rat hepatic stellate cell morphology via regulation of the actin cytoskeleton, Hepatology, 28, 843, 10.1002/hep.510280336

Choi, 2006, Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice, Hepatology, 44, 1267, 10.1002/hep.21375

Schuppan, 1998, Collagens in the liver extracellular matrix bind hepatocyte growth factor, Gastroenterology, 114, 139, 10.1016/S0016-5085(98)70642-0

Schuppan, 2001, Matrix as a modulator of hepatic fibrogenesis, Semin Liver Dis, 21, 351, 10.1055/s-2001-17556

Wells, 2008, The role of matrix stiffness in regulating cell behavior, Hepatology, 47, 1394, 10.1002/hep.22193

Georges, 2007, Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis, Am J Physiol, 293, G1147

Vizzutti, 2007, Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis, Hepatology, 45, 1290, 10.1002/hep.21665

Kazemi, 2006, Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices, J Hepatol, 45, 230, 10.1016/j.jhep.2006.04.006

Rockey, 2008, Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography, Gastroenterology, 134, 8, 10.1053/j.gastro.2007.11.053

Yin, 2007, Assessment of hepatic fibrosis with magnetic resonance elastography, Clin Gastroenterol Hepatol, 5, 1207, 10.1016/j.cgh.2007.06.012

Talwalkar, 2008, Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications, Hepatology, 47, 332, 10.1002/hep.21972

Valencia-Sanchez, 2006, Control of translation and mRNA degradation by miRNAs and siRNAs, Genes Dev, 20, 515, 10.1101/gad.1399806

Rippe, 2004, From quiescence to activation: gene regulation in hepatic stellate cells, Gastroenterology, 127, 1260, 10.1053/j.gastro.2004.08.028

Mann, 2007, Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis, Cell Death Differ, 14, 275, 10.1038/sj.cdd.4401979

Tsukamoto, 2006, Anti-adipogenic regulation underlies hepatic stellate cell transdifferentiation, J Gastroenterol Hepatol, 21, S102, 10.1111/j.1440-1746.2006.04573.x

Kalinichenko, 2003, Foxf1 +/- mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl4 injury, Hepatology, 37, 107, 10.1053/jhep.2003.50005

Jochum, 2001, AP-1 in mouse development and tumorigenesis, Oncogene, 20, 2401, 10.1038/sj.onc.1204389

Smart, 2006, JunD is a profibrogenic transcription factor regulated by Jun N-terminal kinase-independent phosphorylation, Hepatology, 44, 1432, 10.1002/hep.21436

Buck, 2001, C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival, Mol Cell, 8, 807, 10.1016/S1097-2765(01)00374-4

Wandzioch, 2004, Lhx2-/- mice develop liver fibrosis, Proc Natl Acad Sci U S A, 101, 16549, 10.1073/pnas.0404678101

Adachi, 2007, The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells, Gastroenterology, 132, 1434, 10.1053/j.gastro.2007.01.033

Yavrom, 2005, Peroxisome proliferator-activated receptor gamma suppresses proximal alpha1(I) collagen promoter via inhibition of p300-facilitated NF-I binding to DNA in hepatic stellate cells, J Biol Chem, 280, 40650, 10.1074/jbc.M510094200

Galli, 2002, Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro, Gastroenterology, 122, 1924, 10.1053/gast.2002.33666

Haughton, 2006, Pregnane x receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro, Gastroenterology, 131, 194, 10.1053/j.gastro.2006.04.012

Marek, 2005, Pregnenolone-16alpha-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms, Biochem J, 387, 601, 10.1042/BJ20041598

Okuno, 1999, Increased 9,13-di-cis-retinoic acid in rat hepatic fibrosis: implication for a potential link between retinoid loss and TGF-beta mediated fibrogenesis in vivo, J Hepatol, 30, 1073, 10.1016/S0168-8278(99)80262-1

Hellemans, 1999, All-trans and 9-cis retinoic acid alter rat hepatic stellate cell phenotype differentially, Gut, 45, 134, 10.1136/gut.45.1.134

Oakley, 2005, Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis, Gastroenterology, 128, 108, 10.1053/j.gastro.2004.10.003

Mann, 2006, Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis, Cell Death Differ, 14, 275, 10.1038/sj.cdd.4401979

Habens, 2005, Novel sulfasalazine analogues with enhanced NF-kB inhibitory and apoptosis promoting activity, Apoptosis, 10, 481, 10.1007/s10495-005-1877-0

Stefanovic, 1997, Posttranscriptional regulation of collagen alpha1(I) mRNA in hepatic stellate cells, Mol Cell Biol, 17, 5201, 10.1128/MCB.17.9.5201

Stefanovic, 1999, Regulatory role of the conserved stem-loop structure at the 5' end of collagen alpha1(I) mRNA, Mol Cell Biol, 19, 4334, 10.1128/MCB.19.6.4334

Fritz, 2007, RNA-binding protein RBMS3 is expressed in activated hepatic stellate cells and liver fibrosis and increases expression of transcription factor Prx1, J Mol Biol, 371, 585, 10.1016/j.jmb.2007.06.006

Borkham-Kamphorst, 2007, Pro-fibrogenic potential of PDGF-D in liver fibrosis, J Hepatol, 46, 1064, 10.1016/j.jhep.2007.01.029

Wong, 1994, Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture, J Clin Invest, 94, 1563, 10.1172/JCI117497

Pinzani, 1994, Expression of platelet-derived growth factor in a model of acute liver injury, Hepatology, 19, 701, 10.1002/hep.1840190323

Czochra, 2006, Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice, J Hepatol, 45, 419, 10.1016/j.jhep.2006.04.010

Campbell, 2005, Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma, Proc Natl Acad Sci U S A, 102, 3389, 10.1073/pnas.0409722102

Pinzani, 2001, Cytokine receptors and signaling in hepatic stellate cells, Semin Liver Dis, 21, 397, 10.1055/s-2001-17554

Lechuga, 2006, PI3K is involved in PDGF-beta receptor upregulation post-PDGF-BB treatment in mouse HSC, Am J Physiol, 291, G1051

Rovida, 2008, ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells, J Hepatol, 48, 107, 10.1016/j.jhep.2007.08.010

Di Sario, 2003, Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat, Hepatology, 37, 256, 10.1053/jhep.2003.50028

Yoshiji, 2003, Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis, Gut, 52, 1347, 10.1136/gut.52.9.1347

Marra, 1995, Thrombin stimulates proliferation of liver fat-storing cells and expression of monocyte chemotactic protein-1: potential role in liver injury, Hepatology, 22, 780

Marra, 1998, Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury, Hepatology, 27, 462, 10.1002/hep.510270221

Steiling, 2004, Activated hepatic stellate cells express keratinocyte growth factor in chronic liver disease, Am J Pathol, 165, 1233, 10.1016/S0002-9440(10)63383-4

Yu, 2003, Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis, Am J Pathol, 163, 1653, 10.1016/S0002-9440(10)63522-5

Ikeda, 1999, In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation, Hepatology, 29, 1760, 10.1002/hep.510290640

Kinnman, 2000, PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury, Lab Invest, 80, 697, 10.1038/labinvest.3780073

Marra, 1999, Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells, Hepatology, 29, 140, 10.1002/hep.510290107

Bonacchi, 2001, Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes, J Biol Chem, 276, 9945, 10.1074/jbc.M010303200

Melton, 2007, Hepatic stellate cell protrusions couple platelet-derived growth factor-BB to chemotaxis, Hepatology, 45, 1446, 10.1002/hep.21606

Hashmi, 2007, Adenosine inhibits cytosolic calcium signals and chemotaxis in hepatic stellate cells, Am J Physiol, 292, G395

Chan, 2006, Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis, Br J Pharmacol, 148, 1144, 10.1038/sj.bjp.0706812

Ruhl, 2005, Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States, Gastroenterology, 129, 1928, 10.1053/j.gastro.2005.08.056

Tsukada, 2006, Mechanisms of liver fibrosis, Clin Chim Acta, 364, 33, 10.1016/j.cca.2005.06.014

Stefanovic, 2004, TRAM2 protein interacts with endoplasmic reticulum Ca2+ pump Serca2b and is necessary for collagen type I synthesis, Mol Cell Biol, 24, 1758, 10.1128/MCB.24.4.1758-1768.2004

Inagaki, 2007, Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis, Gut, 56, 284, 10.1136/gut.2005.088690

Breitkopf, 2006, TGF-beta/Smad signaling in the injured liver, Z Gastroenterol, 44, 57, 10.1055/s-2005-858989

Liu, 2003, Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta) in quiescent and activated hepatic stellate cells, J Biol Chem, 278, 11721, 10.1074/jbc.M207728200

Uemura, 2005, Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization, Mol Biol Cell, 16, 4214, 10.1091/mbc.E05-02-0149

Wiercinska, 2006, Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells, Hepatology, 43, 1032, 10.1002/hep.21135

Garcia-Trevijano, 1999, Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta-dependent mechanism in rat hepatic stellate cells, Hepatology, 29, 960, 10.1002/hep.510290346

Dooley, 2000, Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts, Hepatology, 31, 1094, 10.1053/he.2000.6126

Paradis, 2002, Effects and regulation of connective tissue growth factor on hepatic stellate cells, Lab Invest, 82, 767, 10.1097/01.LAB.0000017365.18894.D3

Rachfal, 2003, Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis, Hepatol Res, 26, 1, 10.1016/S1386-6346(03)00115-3

Gao, 2004, Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan, J Biol Chem, 279, 8848, 10.1074/jbc.M313204200

Paradis, 2001, High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis, Hepatology, 34, 738, 10.1053/jhep.2001.28055

Grotendorst, 1997, Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts, Cytokine Growth Factor Rev, 8, 171, 10.1016/S1359-6101(97)00010-5

Brigstock, 2003, The CCN family: a new stimulus package, J Endocrinol, 178, 169, 10.1677/joe.0.1780169

Weng, 2007, Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes, Hepatology, 46, 1257, 10.1002/hep.21806

Gressner, 2007, Differential effects of TGF-beta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes, J Hepatol, 47, 699, 10.1016/j.jhep.2007.05.015

Roskams, 2004, Neuroregulation of the neuroendocrine compartment of the liver, Anat Rec, 280, 910, 10.1002/ar.a.20096

Mallat, 2007, Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases, Expert Opin Ther Targets, 11, 403, 10.1517/14728222.11.3.403

Batkai, 2001, Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis, Nat Med, 7, 827, 10.1038/89953

Teixeira-Clerc, 2006, CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis, Nat Med, 12, 671, 10.1038/nm1421

Munoz-Luque, 2008, Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats, J Pharmacol Exp Ther, 324, 475, 10.1124/jpet.107.131896

Ebrahimkhani, 2006, Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats, Gut, 10.1136/gut.2005.076778

De Minicis, 2008, Role of endogenous opioids in modulating Hsc activity in vitro and liver fibrosis in vivo, Gut, 57, 352, 10.1136/gut.2007.120303

Oben, 2004, Hepatic fibrogenesis requires sympathetic neurotransmitters, Gut, 53, 438, 10.1136/gut.2003.026658

Rockey, 1992, Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture, J Submicrosc Cytol Pathol, 24, 193

Saab, 2002, Myosin mediates contractile force generation by hepatic stellate cells in response to endothelin-1, J Biomed Sci, 9, 607, 10.1007/BF02254988

Bataller, 2001, In vitro and in vivo activation of rat hepatic stellate cells results in de novo expression of L-type voltage-operated calcium channels, Hepatology, 33, 956, 10.1053/jhep.2001.23500

Yee, 2001, Ca2+ and rho signaling pathways: two paths to hepatic stellate cell contraction, Hepatology, 33, 1007, 10.1053/jhep.2001.23901

Laleman, 2007, Both Ca2+-dependent and -independent pathways are involved in rat hepatic stellate cell contraction and intrahepatic hyperresponsiveness to methoxamine, Am J Physiol Gastrointest Liver Physiol, 292, G556, 10.1152/ajpgi.00196.2006

Fischer, 2002, Caspase 9-dependent killing of hepatic stellate cells by activated Kupffer cells, Gastroenterology, 123, 845, 10.1053/gast.2002.35384

Martinez-Hernandez, 1995, The extracellular matrix in hepatic regeneration, FASEB J, 9, 1401, 10.1096/fasebj.9.14.7589981

Olaso, 2003, Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis, Hepatology, 37, 674, 10.1053/jhep.2003.50068

Rockey, 2003, Vascular mediators in the injured liver, Hepatology, 37, 4, 10.1053/jhep.2003.50044

Pinzani, 1992, Fat-storing cells as liver-specific pericytes, J Clin Invest, 90, 642, 10.1172/JCI115905

Melton, 2006, [Ca2+]i-independent contractile force generation by rat hepatic stellate cells in response to endothelin-1, Am J Physiol, 290, G7

Reynaert, 2002, Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension, Gut, 50, 571, 10.1136/gut.50.4.571

Sherman, 1990, Hepatic microvascular changes associated with development of liver fibrosis and cirrhosis, Am J Physiol, 258, H460

Nakata, 2002, Hemodynamics in the microvasculature of thioacetamide-induced cirrhotic rat livers, Hepatogastroenterology, 49, 652

Tugues, 2007, Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats, Hepatology, 46, 1919, 10.1002/hep.21921

Takeji, 2006, Smooth muscle alpha-actin deficiency in myofibroblasts leads to enhanced renal tissue fibrosis, J Biol Chem, 281, 40193, 10.1074/jbc.M602182200

Guo, 2007, Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections, Nat Genet, 39, 1488, 10.1038/ng.2007.6

Marra, 2002, Chemokines in liver inflammation and fibrosis, Front Biosci, 7, d1899, 10.2741/marra

Bonacchi, 2003, The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C, Gastroenterology, 125, 1060, 10.1016/S0016-5085(03)01194-6

Friedman, 2008, Hepatic stellate cells—protean, multifunctional, and enigmatic cells of the liver, Physiol Rev, 88, 125, 10.1152/physrev.00013.2007

Benyon, 2001, Extracellular matrix degradation and the role of hepatic stellate cells, Semin Liver Dis, 21, 373, 10.1055/s-2001-17552

Arthur, 1992, Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes, Biochem J, 287, 701, 10.1042/bj2870701

Han, 2007, A matrix metalloproteinase-9 activation cascade by hepatic stellate cells in trans-differentiation in the three-dimensional extracellular matrix, J Biol Chem, 282, 12928, 10.1074/jbc.M700554200

Vyas, 1995, Rat hepatic lipocytes synthesize and secrete transin (stromelysin) in early primary culture, Gastroenterology, 109, 889, 10.1016/0016-5085(95)90399-2

Schaefer, 2003, Reciprocal modulation of matrix metalloproteinase-13 and type I collagen genes in rat hepatic stellate cells, Am J Pathol, 162, 1771, 10.1016/S0002-9440(10)64312-X

Issa, 2004, Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking, Gastroenterology, 126, 1795, 10.1053/j.gastro.2004.03.009

Nagula, 2006, Histological-hemodynamic correlation in cirrhosis—a histological classification of the severity of cirrhosis, J Hepatol, 44, 111, 10.1016/j.jhep.2005.07.036

Li, 2001, Transgenic mice with inactive alleles for procollagen N-proteinase (ADAMTS-2) develop fragile skin and male sterility, Biochem J, 355, 271, 10.1042/0264-6021:3550271

Kesteloot, 2007, ADAM metallopeptidase with thrombospondin type 1 motif 2 inactivation reduces the extent and stability of carbon tetrachloride-induced hepatic fibrosis in mice, Hepatology, 46, 1620, 10.1002/hep.21868

Niiya, 2006, Increased ADAMTS-13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo, J Thromb Haemost, 4, 1063, 10.1111/j.1538-7836.2006.01893.x

Duffield, 2005, Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair, J Clin Invest, 115, 56, 10.1172/JCI200522675

Fallowfield, 2007, Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis, J Immunol, 178, 5288, 10.4049/jimmunol.178.8.5288

Murphy, 2002, Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis, J Biol Chem, 277, 11069, 10.1074/jbc.M111490200

Yoshiji, 2002, Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse, Hepatology, 36, 850, 10.1053/jhep.2002.35625

Roderfeld, 2006, Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice, FASEB J, 20, 444, 10.1096/fj.05-4828com

Knittel, 1996, Gene expression and regulation of plasminogen activator inhibitor type I in hepatic stellate cells of rat liver, Gastroenterology, 111, 745, 10.1053/gast.1996.v111.pm8780581

Zhang, 1999, Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells, J Hepatol, 31, 703, 10.1016/S0168-8278(99)80351-1

Fibbi, 1999, Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor, Hepatology, 29, 868, 10.1002/hep.510290343

Olaso, 2001, DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells, J Clin Invest, 108, 1369, 10.1172/JCI200112373

Gaca, 2003, Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: evidence for matrix-dependent deactivation of stellate cells, Matrix Biol, 22, 229, 10.1016/S0945-053X(03)00017-9

Guyot, 2007, Fibrogenic cell fate during fibrotic tissue remodelling observed in rat and human cultured liver slices, J Hepatol, 46, 142, 10.1016/j.jhep.2006.08.013

Neuschwander-Tetri, 2003, Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference, Hepatology, 37, 1202, 10.1053/jhep.2003.50193

London, 2007, Pathogenesis of NASH: animal models, Clin Liver Dis, 11, 55, 10.1016/j.cld.2007.02.010

Ikejima, 2007, Role of adipocytokines in hepatic fibrogenesis, J Gastroenterol Hepatol, 22, S87, 10.1111/j.1440-1746.2007.04961.x

Ikejima, 2002, Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat, Gastroenterology, 122, 1399, 10.1053/gast.2002.32995

Leclercq, 2002, Leptin is essential for the hepatic fibrogenic response to chronic liver injury, J Hepatol, 37, 206, 10.1016/S0168-8278(02)00102-2

Lin, 2006, Leptin increases tissue inhibitor of metalloproteinase I (TIMP-1) gene expression by a specificity protein 1/signal transducer and activator of transcription 3 mechanism, Mol Endocrinol, 20, 3376, 10.1210/me.2006-0177

Marra, 2005, Adipokines and liver fibrosis, Eur Rev Med Pharmacol Sci, 9, 279

Kamada, 2003, Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin, Gastroenterology, 125, 1796, 10.1053/j.gastro.2003.08.029

Lonardo, 2004, Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease, Gastroenterology, 126, 586, 10.1053/j.gastro.2003.11.020

Fartoux, 2005, Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C, Gut, 54, 1003, 10.1136/gut.2004.050302

Moucari, 2008, Insulin resistance in chronic hepatitis C: association with genotypes I and 4, serum HCV RNA level, and liver fibrosis, Gastroenterology, 134, 416, 10.1053/j.gastro.2007.11.010

Hezode, 2005, Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C, Hepatology, 42, 63, 10.1002/hep.20733

Hezode, 2008, Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C, Gastroenterology, 134, 432, 10.1053/j.gastro.2007.11.039

Jeong, 2008, Paracrine activation of hepatic CB(1) receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver, Cell Metab, 7, 227, 10.1016/j.cmet.2007.12.007

Bataller, 2004, Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells, Gastroenterology, 126, 529, 10.1053/j.gastro.2003.11.018

Shin, 2005, HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1, Exp Mol Med, 37, 138, 10.1038/emm.2005.19

Mazzocca, 2005, Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells, J Biol Chem, 280, 11329, 10.1074/jbc.M410161200

Schulze-Krebs, 2005, Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells, Gastroenterology, 129, 246, 10.1053/j.gastro.2005.03.089

Pohlmann, 2003, Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR, J Virol, 77, 4070, 10.1128/JVI.77.7.4070-4080.2003

Tuyama, 2007, HIV entry and replication in stellate cells promotes cellular activation and fibrogenesis: implications for hepatic fibrosis in HIV/HCV co-infection, Hepatology, 46, 80A

Brau, 2006, Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy, J Hepatol, 44, 47, 10.1016/j.jhep.2005.07.006

Kordes, 2007, CD133+ hepatic stellate cells are progenitor cells, Biochem Biophys Res Commun, 352, 410, 10.1016/j.bbrc.2006.11.029

Roskams, 2006, Different types of liver progenitor cells and their niches, J Hepatol, 45, 1, 10.1016/j.jhep.2006.05.002

Sicklick, 2005, Role for hedgehog signaling in hepatic stellate cell activation and viability, Lab Invest, 85, 1368, 10.1038/labinvest.3700349

Yang, 2008, Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells, J Hepatol, 48, 98, 10.1016/j.jhep.2007.07.032

Myung, 2007, Wnt signaling enhances the activation and survival of human hepatic stellate cells, FEBS Lett, 581, 2954, 10.1016/j.febslet.2007.05.050

Taipale, 2001, The Hedgehog and Wnt signalling pathways in cancer, Nature, 411, 349, 10.1038/35077219

Lafdil, 2006, Induction of Gas6 protein in CCl4-induced rat liver injury and anti-apoptotic effect on hepatic stellate cells, Hepatology, 44, 228, 10.1002/hep.21237

Goodman, 2007, Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis, Hepatology, 45, 886, 10.1002/hep.21595

Pockros, 2007, Final results of a double-blind, placebo-controlled trial of the anti-fibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis, Hepatology, 45, 569, 10.1002/hep.21561

D'Amico, 2006, Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies, J Hepatol, 44, 217, 10.1016/j.jhep.2005.10.013